......snip......
In drug discovery, my first boss told us of a candidate 5-lipoxygenase inhibitor (target: psoriasis) that needed an official name for clinical studies. Since it contained a chloronaphthalene, and 5-LOIs ended in “olac”, the name clonapolac was suggested, with emphasis on syllables one and three. Then the boss pronounced it with emphasis on syllables one and three, accompanied by the Ph. D. Laugh, straight face but mirthful eyes, “you can see why that didn’t last”. They broke with the pattern and named the molecule lonapalene.
My dad (doctor of electrical engineering) often used the Ph. D. Laugh at home, especially when he tutored our high school class in math.